Fidelity Investments
AYTU icon

Fidelity Investments’s AYTU BioPharma AYTU Stock Holding History

Fidelity Investments’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$9 – 5431
2025
Q3 		$9 Buy
+5
New +$12 ﹤0.01% 5335
2024
Q2 		– Sell
-2
Closed -$6 – 5370
2024
Q1 		$6 Buy
2
+1
+100% +$3 ﹤0.01% 5292
2023
Q4 		$3 Sell
1
-3
-75% -$8 ﹤0.01% 5386
2023
Q3 		$11 Sell
4
-1
-20% -$2 ﹤0.01% 5165
2023
Q2 		$8 Buy
+5
New +$10 ﹤0.01% 5284
2022
Q4 		– Sell
-600
Closed -$2K – 5348
2022
Q3 		$2K Buy
+600
New +$4.55K ﹤0.01% 4521
2021
Q4 		– Sell
-5
Closed – – 4320
2021
Q3 		$0 Buy
+5
New +$375 ﹤0.01% 4328
2021
Q2 		– Hold
0
– – – 4226
2021
Q1 		– Sell
-8
Closed -$1K – 3966
2020
Q4 		$1K Buy
+8
New +$1.46K ﹤0.01% 3660

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fidelity Investments's AYTU Position: Q4 2025 in Review

Fidelity Investments sold out of AYTU BioPharma (AYTU) in Q4 2025, closing a stake of 5 shares — an estimated $9 sold.

Fidelity Investments first reported a position in AYTU in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q3 2022. 39 funds tracked by Wall St. Rank hold AYTU as of Q4 2025.

  • Fidelity Investments reported no remaining AYTU BioPharma position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 5 AYTU BioPharma shares in Q4 2025, an estimated $9.
  • Fidelity Investments first reported a position in AYTU BioPharma in Q4 2020 and held it in 8 quarters.
  • Fidelity Investments's AYTU BioPharma position peaked at $2K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.